| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.37 | 3e-08 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-08 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.13 | 0.004 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.097 | 0.006 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.01 |